The FDA rejected a Duchenne muscular dystrophy cell therapy from Capricor Therapeutics, as a larger study of the treatment ...

Now, though, there are some bipartisan health care policies, from pharmacy-benefit manager reform to Medicare doctor payment ...

As I reflected on her comments, I realized that tucked within her criticism was an unspoken compliment: She felt comfortable ...

Future doctors from underserved communities will have a harder time paying for med school under the new federal loan caps, ...

The California Institute for Regenerative Medicine and its partners are selling thousands of stem cell samples before many of ...

A court battle between two of the nation’s largest biotechs is testing the legal limits of how far drugmakers can go in using ...

Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

A court battle between Regeneron and Amgen is testing the legal limits of how far drugmakers can go in using patents to ...

On this week's episode of "The Readout LOUD": a closer look at the NIH’s grant-cutting legal playbook, FDA transparency ...

A high-stakes legal fight between Regeneron and Amgen over the blockbuster eye drug Eylea is putting the U.S. patent system ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Next month will be the first opportunity to gauge the commercial launch of a new treatment for Prader-Willi syndrome, a rare ...